Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension

Abstract

We conducted a randomised, double-blind, parallel design study comparing the efficacy and tolerability of the angiotensin II receptor antagonist, losartan, alone or with low-dose hydrochlorothiazide (HCTZ) to the dihydropyridine calcium channel blocker, nifedipine GITS (gastro-intestinal therapeutic system), in elderly patients (65 years old) with a diastolic blood pressure (DBP) between 95 and 115 mm Hg. After a placebo wash out period, 140 patients were randomly assigned to receive either losartan 50 mg or nifedipine GITS 30 mg. Patients were evaluated at 4-week intervals during a 12-week treatment period. Patients receiving losartan had HCTZ 12.5 mg added and increased to 25 mg to reduce DBP <90 mm hg. patients receiving nifedipine gits had their dose increased to 60 mg and 90 mg to reduce dbp <90 mm hg. efficacy, tolerability and quality of life were assessed during the 12 weeks on each regimen. patients treated with the losartan regimen (n = 73) had reductions in trough sitting DBP of −10, −13, and −13 mm Hg after 4, 8, and 12 weeks of therapy, respectively. Patients receiving the nifedipine GITS regimen (n = 67) had DBP reductions of −14, −15, and −15 mm Hg, respectively. There were no significant differences in the DBP response between the treatment groups except at week 4 (P < 0.05). similar reductions in systolic bp (sbp) between the two treatment groups were observed at all time points. the percentages of patients in the two treatment groups reaching goal dbp (<90 mm hg or dbp 90 mm hg with a reduction from a baseline of 10 mm hg) were comparable (81% on the losartan regimen and 90% on the nifedipine gits regimen). there were significantly more adverse events reported in patients receiving nifedipine gits when compared to the losartan regimen (54% vs 36%, P < 0.05). a patient-reported symptom inventory also showed that swollen ankles was bothersome in significantly more patients treated with the nifedipine gits regimen when compared to the losartan regimen (24% vs 5%, P = 0.001). Thus, in elderly patients with diastolic hypertension, a regimen of losartan alone or with HCTZ has similar efficacy to a regimen of nifedipine GITS with greater tolerability and less symptom bother due to swollen ankles.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Conlin, P., Elkins, M., Liss, C. et al. A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension. J Hum Hypertens 12, 693–699 (1998). https://doi.org/10.1038/sj.jhh.1000687

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1000687

Keywords

This article is cited by

Search

Quick links